|
|
Espanol
Programa de Pérdida de Peso con Semaglutida y Tirzepatida 1. Evaluación Inicial. Antes de comenzar cualquier programa de pérdida de peso, es crucial realizar una evaluación médica completa que incluya: English
**Weight Loss Program with Semaglutide and Tirzepatide** **1. Initial Evaluation** Before starting any weight loss program, it is crucial to conduct a comprehensive medical evaluation that includes: - **Complete medical history:** Including a history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular diseases, and other health issues. - **Physical examination:** Measurement of body mass index (BMI), waist circumference, blood pressure, and other relevant parameters. - **Laboratory tests:** Including fasting glucose, hemoglobin A1c, lipid profile, liver and kidney function, and others as needed. **2. Medication Selection** - **Semaglutide:** A GLP-1 receptor agonist (glucagon-like peptide-1), approved for the treatment of obesity and type 2 diabetes. - **Initial dose:** 0.25 mg once a week, gradually increasing every 4 weeks until reaching the maintenance dose of 1 mg once a week. **3. Nutrition Plan** - **Balanced diet:** Based on calorie reduction, rich in fruits, vegetables, lean proteins, and whole grains. - **Portion control:** Use smaller plates and measure portions to avoid overeating. - **Food journal:** Keep a food diary to monitor calorie intake and eating patterns. **4. Physical Activity** - **Aerobic exercise:** At least 150 minutes per week of moderate activity (such as walking, swimming, or cycling) or 75 minutes per week of vigorous activity (such as running or aerobics classes). - **Strength training:** At least two days a week, focusing on all major muscle groups. - **Gradual increase:** Start with manageable levels of activity and gradually increase the duration and intensity. |
|